RPS Support Alerts

The RPS Support team are developing and publishing regular Support Alerts to help support you in your day to day roles. These will cover a wide range of subjects ranging from legal and ethical issues to clinical matters and aim to be informative, supportive and user-friendly. Topics will be identified as part of horizon scanning by the RPS Support team but will also be produced in response to real queries and issues raised by members.

This section also includes information about drug and device recalls, patient safety notices, health professional letters and other important communications concerning patient safety, thus enabling you to ensure that you meet any necessary clinical governance requirements.

To recieve these alerts via email please subscribe by visiting My Preferences.

Support Alerts archive


17/05/2012 - Class 3 Medicines Alert (Action Within 5 days): Fulsovin 125mg/5ml Oral Suspension (Kappin Limited) 

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall .....more 

17/05/2012 - Medical Device Alert: Clever Chek blood glucose monitoring system (BBI Healthcare) 

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert .....more 

14/05/2012 - Veterinary Medicines - Advice for Pharmacists 

The Veterinary Medicines Directorate (VMD) have published a leaflet explaining the specific requirements .....more 

09/05/2012 - Class 3 Medicines Alert (Action Within 5 days): Levothyroxine 100mcg Tablets in Teva UK and Numark liveries 

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall .....more 

08/05/2012 - Changes to wholesale dealing arrangements (supply of medicines from a pharmacy) 

A major change to Medicines Act 1968 will come into force from July 2012.

Section .....more 

03/05/2012 - Class 4 medicines alert issued for Priadel Liquid (Lithium Citrate 520mg/5ml equivalent to Lithium Carbonate 204mg/5ml) 

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 4 medicines alert .....more